Name | BML-259 |
Synonyms | BML-259 CAY10554 2-phenyl-N-(5-propan-2-yl-1,3-thiazol-2-yl)acetamide Benzeneacetamide, N-[5-(1-methylethyl)-2-thiazolyl]- |
CAS | 267654-00-2 |
Molecular Formula | C14H16N2OS |
Molar Mass | 260.35 |
Melting Point | 150-152℃ |
Solubility | DMSO:15mg/ml |
Appearance | White solid. |
Color | white |
Storage Condition | RT |
Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months. |
Use | BML-259 is a potent cyclin-dependent kinase 5 (Cdk5) inhibitor with IC50 of 64 and 98 nM for Cdk5 and Cdk2, respectively. |
Reference Show more | 1. Kaźmierczak A, et al. A novel mechanism of non-Aβ component of Alzheimer's disease amyloid (NAC) neurotoxicity. Interplay between p53 protein and cyclin-dependent kinase 5 (Cdk5). Neurochem Int. 2011;58(2):206-214. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.841 ml | 19.204 ml | 38.409 ml |
5 mM | 0.768 ml | 3.841 ml | 7.682 ml |
10 mM | 0.384 ml | 1.92 ml | 3.841 ml |
5 mM | 0.077 ml | 0.384 ml | 0.768 ml |